Analytical Validation and Clinical Sensitivity of the Belay Summit™ 2.0 Cerebrospinal Fluid Liquid Biopsy Test—An Expanded Comprehensive Genomic Profiling Platform for Central Nervous System Malignancies.

Saved in:
Bibliographic Details
Title: Analytical Validation and Clinical Sensitivity of the Belay Summit™ 2.0 Cerebrospinal Fluid Liquid Biopsy Test—An Expanded Comprehensive Genomic Profiling Platform for Central Nervous System Malignancies.
Authors: Khurana, Sakshi1 (AUTHOR), Keo, Viriya1,2 (AUTHOR), Larson, Alexandra1 (AUTHOR), Udhane, Vindhya1,2 (AUTHOR), Adams, Jennifer N.1 (AUTHOR), Acevedo, Anthony1 (AUTHOR), Peltier, Tarin1 (AUTHOR), Sanchez, Daniel1 (AUTHOR), Domagala, Brett A.1 (AUTHOR), Vo, Samantha A.1 (AUTHOR), Mitchell, Kathleen1 (AUTHOR), Ellis, Dean1 (AUTHOR), Muhammedov, Baymuhammet1 (AUTHOR), Al-Saffar, Samer I.1 (AUTHOR), Hernandez, Kyle M.1 (AUTHOR), Bettegowda, Chetan2 (AUTHOR), Douville, Christopher2 (AUTHOR), Schilter, Kala F.1 (AUTHOR), Nie, Qian1 (AUTHOR), Reddi, Honey V.1 (AUTHOR)
Source: Cancers. Jan2026, Vol. 18 Issue 2, p256. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers18020256